Sector pending / Pharmaceutical PreparationsUpdated 2026-05-10 22:07 UTC

FRA/4E2 stock hub

FRA/4E2 has a live ticker hub with the latest available market, valuation, profitability, growth, ownership, and risk indicators.

Browse stocks

FRA/4E2is not in this month’s coverageGet our monthly research letter — no spam

Fair value midpoint

n/a

Fair value pending

Upside to midpoint

n/a

Based on latest report

Confidence

n/a

Data quality and model convergence

Market cap

652.3M

Frankfurt Stock Exchange

Market data

Price

Recent price action with selectable time range.

FRA/4E2FRA/4E2

—

Loading chart…

In the news

Latest news · FRA/4E2

Recent company headlines from major financial publishers.

—

Fetching the latest headlines.

—

Fetching the latest headlines.

—

Fetching the latest headlines.

Calendar

Next earnings

Upcoming earnings date and setup when available.

Upcoming

DateLoading

Window—

EPS estimate—

Revenue estimate—

Sector context

Where the current metrics sit

Percentiles come from the backend screener cohort cache for the ticker's country and sector.

Forward P/En/a

P25 n/aP50 n/aP75 n/a

Trailing P/En/a

P25 n/aP50 n/aP75 n/a

ROE-94

P25 n/aP50 n/aP75 n/a

ROIC-57.6

P25 n/aP50 n/aP75 n/a

Benchmarks - 1M

S&P 500n/a

Nasdaq Compositen/a

Dow Jones Industrial Averagen/a

Russell 2000n/a

Indicator catalog

All FRA/4E2 market and fundamental indicators

A searchable catalog of the available market, valuation, profitability, growth, balance-sheet, ownership, and analyst metrics for this ticker.

Available fields

122

Groups with data

Currency

USD

Showing 122 of 122 available metrics for this ticker.

Profile and market data

Ticker identity, listing, currency, market cap, and source dates.

Metric	Value
Country	United States
Country code	DE
Employees	17
Employees Change	-3%
Employees Change Percent	-15
Enterprise value	EUR 573.3M
Exchange	Frankfurt Stock Exchange
Financial currency	USD
First seen	2026-05-10
Industry	Pharmaceutical Preparations
Last refreshed	2026-05-10
Market cap	EUR 652.3M
Price	EUR 6.1
Price currency	EUR
Sic	2834
Symbol	fra/4E2
Website	https://www.relmada.com

Valuation

Multiples, yields, enterprise-value ratios, and valuation checks.

Metric	Value
Earnings Yield	-7.49%
EV Earnings	-11.73x
P/B ratio	8.85x

Profitability

Margins, returns on capital, cash conversion, and quality metrics.

Metric	Value
Net Income	EUR -48.9M
Profit Per Employee	EUR -2.9M
ROA	-50.24
Roa5y	-54.95
ROCE	-64.18
ROE	-94.05
Roe5y	-96.82
ROIC	-57.57

Growth

Revenue, earnings, cash-flow, and forward growth indicators.

Metric	Value
Cagr1y	1,910.71%

Financial strength

Debt, cash, solvency, accounting-quality, and balance-sheet signals.

Metric	Value
Assets	EUR 80.1M
Cash	EUR 79.2M
Current Assets	EUR 79.7M
Current Liabilities	EUR 5.5M
Equity	EUR 73.7M
Liabilities	EUR 6.4M
Long Term Assets	EUR 367,920
Long Term Liabilities	EUR 927,632
Net Cash	EUR 79.2M
Net Cash By Market Cap	EUR 12.14
Net Cash Growth	107.1%
Net Debt Equity	EUR -1.08
Tangible Book Value	EUR 73.7M
Tangible Book Value Per Share	EUR 1

Liquidity

Current-asset coverage and working-capital efficiency metrics.

Metric	Value
Current ratio	14.62
Net Working Capital	EUR -4.6M
Quick ratio	14.46
Working Capital	EUR 74.6M

Dividends and buybacks

Dividend yield, payout, buybacks, and shareholder-yield indicators.

Metric	Value
Buyback Yield	-30.89%

Performance and technicals

Returns, volatility, beta, momentum, RSI, and moving-average context.

Metric	Value
1Y total return	1,906.58%
200-day SMA	3.05
50-day SMA	5.44
50-day SMA vs 200-day SMA	50over200
All Time High	6.5
All Time High Change	-6.15%
All Time High Date	2026-05-07
All Time Low	0.21
All Time Low Change	2,777.36%
All Time Low Date	2025-04-09
ATR	0.2
Ch YTD	67.58
High	6.1
High52	6.5
High52 Date	2026-05-07
High52ch	-6.15%
Low	6.1
Low52	0.29
Low52 Date	2025-05-08
Low52ch	2,018.06%
Ma50ch	12.17%
Price vs 200-day SMA	100.07%
RSI	54.54
RSI Monthly	91.24
RSI Weekly	73.8
Sharpe ratio	2.73x
Sortino ratio	6.25
Total Return	-30.89%
Tr YTD	67.58
Tr1m	6.09%
Tr1w	-3.17%
Tr3m	107.48%

Analyst estimates

Ratings, targets, revisions, and forward estimate fields.

Metric	Value
Operating Income	EUR -47.9M

Ownership and float

Institutional, insider, float, short-interest, and share-count fields.

Metric	Value
Float	90,264,647%
Shares Insiders	4.68%
Shares Institutions	44.47%
Shares Qo Q	84.07%
Shares Yo Y	30.89%
Short Ratio	3.46

Other indicators

Additional ticker metrics that do not fit the primary research groupings yet.

Metric	Value
Average Volume	4.5x
Bv Per Share	1
Ch1m	6.09
Ch1w	-3.17
Ch1y	1,906.6
Ch3m	107.5
Ch6m	179.8
Change	-6.15%
Change From Open	0
Close	6.5
Days Gap	-6.15
Earnings Date	2026-05-12
EBIT	EUR -47.9M
EPS	EUR -1.24
F Score	2
Financing CF	79,689,147
Fiscal Year End	December
Founded	2,004
Investing CF	-40,999,395
Is Primary Listing	0
Last Earnings Date	2026-03-19
Last Report Date	2025-12-31
Ma150	3.78
Ma150ch	61.33%
Ma20	6.05
Ma20ch	0.88%
Net CF	-307,026
Next Earnings Date	2026-05-12
Open	6.1
Price Date	2026-05-08
Ptbv Ratio	8.85
Relative Volume	20x
Share Based Comp	13,513,814
Tr6m	179.82%
Volume	0

Fast facts

Decision checkpoints

A compact product layer over the same report payload.

Risk gate

n/a

Named kill scenarios are reviewed before any bullish rating can stand.

Moat score

n/a

Business quality stays separate from stock attractiveness.

Forward P/E

n/a

Valuation uses the full report model stack, not a single multiple.

Next action

Research pending

Final action steps are kept in the recommendation tab.

Income

Does FRA/4E2 pay a dividend?

Capital-return profile for this ticker.

Performance

FRA/4E2 stock returns vs the market

Total return (incl. dividends) compared to S&P 500.

Ownership

Who owns FRA/4E2?

Insider, institutional, and short-interest positioning.

Institutional ownership

+44.5%

Share of float held by funds and institutions

Insider ownership

+4.7%

Stake held by company insiders. Higher generally signals alignment.

Negative means the company is buying back shares.

Technical

FRA/4E2 momentum and risk profile

RSI, moving-average stack, beta, and risk-adjusted return.

RSI (14)

54.5

Neutral momentum band

Price vs 200-day MA

+100.1%

50/200-day relationship not available

Beta (5Y)

n/a

Sensitivity to the broader market

Sharpe ratio

2.73

Risk-adjusted return — higher is better; >1.0 is solid.

Questions

About FRA/4E2

Hub-level FAQ points readers to the deeper analysis pages.

What is the current fra/4E2 stock rating?

fra/4E2 is currently shown with the latest rating in the latest report. The hub links directly to the full analysis surface where the rating, fair-value bridge, risks, and scorecard are documented together.

Where can I read the full fra/4E2 analysis?

The full report lives at /stocks/fra/4E2/analysis. The bare ticker page is a product hub that summarizes the latest read and sends readers into the relocated analysis tabs without making the analysis surface depend on the hub.

What fair-value range is used for fra/4E2?

The latest report frames fra/4E2 around the latest fair-value range. Treat that range as the entry point, then check the valuation, sensitivity, and bear-case tabs before making an investment decision.

How often is the fra/4E2 page updated?

The hub updates with the latest published stock report and live backend market data. The analysis pages remain reachable under /analysis, so a hub rollback does not remove the report reader.